| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367637 Composition for treating arthritic disorder |
| 02/05/2013 | US8367619 Methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression |
| 02/05/2013 | US8367614 Rheumatoid arthritis-preventive agent for oral intake |
| 02/05/2013 | US8367602 Consensus peptides and a method for inducing biomineralization |
| 02/05/2013 | US8367100 Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain |
| 02/05/2013 | US8367063 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 02/05/2013 | CA2629977C Extract of dioscorea sp. and the medical uses thereof |
| 02/05/2013 | CA2557766C Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 02/05/2013 | CA2557320C Fused heterocyclic derivatives for prevention or treatment of hyperglycemia |
| 02/05/2013 | CA2556931C Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 for the prophylaxis of bone diseases |
| 02/05/2013 | CA2547617C Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 01/31/2013 | WO2013015611A2 Composition for preventing damage to chondrocytes and regenerating same, including yeast hydrolysate as an active ingredient |
| 01/31/2013 | WO2013015541A1 Pharmaceutical formulations of bisphosphonate with enhanced oral bioavailability |
| 01/31/2013 | WO2013013490A1 Use of medicament targeting cyslt1 in preparation of drug for prevention or treatment of autoimmune diseases |
| 01/31/2013 | WO2012037043A9 Treatment of autoimmune inflammation using mir-155 |
| 01/31/2013 | WO2010149810A3 In vitro method for the prognosis or prediction of the response in patients with rheumatoid arthritis treated with agents that recognize the cd20 membrane receptor in b lymphocytes |
| 01/31/2013 | US20130030058 Kit and method for producing bone cement |
| 01/31/2013 | US20130030050 Treatment of osteoporosis |
| 01/31/2013 | US20130030046 Use of black soybean hull extracts in manufacture of products for preventing and treating osteoarthritis |
| 01/31/2013 | US20130030045 Method of preventing and treating osteoporosis |
| 01/31/2013 | US20130030000 Pharmaceutical compositions for the treatment of pain and other indications |
| 01/31/2013 | US20130029996 Special composition for the use thereof as a drug |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029960 Enhanced bone healing |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029948 Heterocyclic autotaxin inhibitors and uses thereof |
| 01/31/2013 | US20130029939 Novel glucokinase activators and methods of using same |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | US20130029292 Method of implanting mesenchymal stem cells for natural tooth regeneration in surgically prepared extraction socket and compositions thereof |
| 01/31/2013 | US20130028996 Bioactive botanical cosmetic compositions and processes for their production |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028973 Particulate comprising a calcium-containing compound and a sugar alcohol |
| 01/31/2013 | US20130028937 Co-crystals of venlafaxine and celecoxib |
| 01/31/2013 | US20130028916 Antagonist anti-il-7 receptor antibodies and methods |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | US20130028892 Method of treating osteoarthritis with an antibody to ngf |
| 01/31/2013 | US20130028887 Phenylacetic acid compound |
| 01/31/2013 | US20130028881 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 01/31/2013 | US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| 01/31/2013 | CA2843144A1 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture |
| 01/31/2013 | CA2841541A1 Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene |
| 01/31/2013 | CA2816207A1 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis |
| 01/30/2013 | EP2551342A2 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells |
| 01/30/2013 | CN202699645U Musk analgesic rheumatoid plaster |
| 01/30/2013 | CN202699644U Recovery filtering device for blood serum or cell culture supernatant |
| 01/30/2013 | CN102906095A Pyrrolopyrazine derivatives as SYK and JAK inhibitors |
| 01/30/2013 | CN102905714A Composition comprising coumestrol or bean extract containing coumestrol |
| 01/30/2013 | CN102905680A Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate |
| 01/30/2013 | CN102899287A Method for inducing differentiation from mesenchymal stem cells to cartilage cells and application of mesenchymal stem cells in osteoarthritis |
| 01/30/2013 | CN102899261A Isolated bifidobacterium longum subsp. longum capable of producing high cell immunity reaction |
| 01/30/2013 | CN102899231A Deficiency-tonifying and cold-dispelling traditional Chinese medicine health wine and preparation method thereof |
| 01/30/2013 | CN102898466A Preparation method of sodium ibandronate |
| 01/30/2013 | CN102898432A Tricyclic compound |
| 01/30/2013 | CN102898417A Benzo-hexahydric nitrogenous heterocycle derivative |
| 01/30/2013 | CN102898381A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898380A Amine salts of a CRTH2 antagonist |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102898322A Compound and preparation method and application thereof |
| 01/30/2013 | CN102898284A 3-allyl-[1,1'-biphenyl]-4-phenol, derivatives, preparation methods and uses thereof |
| 01/30/2013 | CN102895704A Biological activity factor composition for promoting ossification and vascularization |
| 01/30/2013 | CN102895661A Application of medicine targeting CysLT1 in preparing medicines for preventing or treating autoimmune diseases |
| 01/30/2013 | CN102895652A Method for promoting osteoblast differentiation by using Runx2 and Osterix and application thereof |
| 01/30/2013 | CN102895630A Preparation technology and production method for integrated new formulation of astragalus and cinnamon twig five agents decoction |
| 01/30/2013 | CN102895625A Preparation technology and production method for integrated new formulation of cassia twig-monkshood decoction |
| 01/30/2013 | CN102895618A Preparation technology and production method for integrated new formulation of snakegourd root and cassia twig decoction |
| 01/30/2013 | CN102895617A Preparation technology and production method for integrated new formulation of bighead atractylodes rhizome and monkshood decoction |
| 01/30/2013 | CN102895613A Preparation technology and production method for integrated new formulation of cassia twig plus kudzu root decoction |
| 01/30/2013 | CN102895572A Traditional Chinese medical composition for treatment of rheumatoid arthritis |
| 01/30/2013 | CN102895553A Preparation technology and production method for integrated new formulation of ephedra, apricot kernel, coix and licorice decoction |
| 01/30/2013 | CN102895539A Preparation technology and production method for integrated new formulation of white tiger decoction plus cinnamon twig |
| 01/30/2013 | CN102895533A Traditional Chinese medical preparation for treatment of cervical vertigo |
| 01/30/2013 | CN102895525A Chinese herbal medicine for rapidly healing fractured bones |
| 01/30/2013 | CN102895510A Traditional Chinese medicine for treating hyperosteogeny |
| 01/30/2013 | CN102895504A Drug wine for treating hyperosteogeny |
| 01/30/2013 | CN102895480A Chinese medicine for treating bone spur |
| 01/30/2013 | CN102895469A Drug for treating rheumatoid arthritis |
| 01/30/2013 | CN102895460A Traditional Chinese medicine composition for fracture and soft tissue injury |
| 01/30/2013 | CN102895447A Chinese medicinal ointment for treating orthopaedic diseases and preparation method thereof |
| 01/30/2013 | CN102895441A Traditional Chinese medicine for treating acute lumbar muscle sprain |
| 01/30/2013 | CN102895415A Preparation method for five spice-nine rattan medicinal liquor |
| 01/30/2013 | CN102895404A Compound drug for arthromeningitis and method for preparing compound drug for arthromeningitis |
| 01/30/2013 | CN102895403A Medicine for treating avascualr necrosis of femoral head and restoring growth of necrotic bone tissues |
| 01/30/2013 | CN102895395A Preparation technology and production method for integrated new formulation of rhubarb and eupolnhagea pill |
| 01/30/2013 | CN102895394A Preparation technology for integrated new formulation of radix stephaniae tetrandrae and rehmannia decoction |
| 01/30/2013 | CN102895365A External ointment for treating bone injury and orthopedics inflammation |
| 01/30/2013 | CN102895348A Pharmaceutical compositions for treating rheumatic joint disease, preparation method thereof and use thereof |
| 01/30/2013 | CN102895337A Medicine for treating gout |
| 01/30/2013 | CN102895336A Preparation technology and production method for integrated new formulation of aconite decoction |
| 01/30/2013 | CN102895320A Medicinal food formula and medicinal edible preparation for preventing and treating hyperuricemia and gout |
| 01/30/2013 | CN102895311A Preparation method of illicium henryi injecta |